Epigenetic Changes in Endothelial Progenitors as a Possible Cellular Basis for Glycemic Memory in Diabetic Vascular Complications

Journal of Diabetes Research

Volumn 2015, Issue , 2015, Pages

  Rajasekar, Poojitha ^a   O'Neill, Christina L ^a   Eeles, Lydia ^a   Stitt, Alan W ^a   Medina, Reinhold J ^a  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT; MICRORNA;

CELL DIFFERENTIATION; CELL ISOLATION; CLINICAL TRIAL (TOPIC); DIABETIC ANGIOPATHY; DNA METHYLATION; ENDOTHELIAL PROGENITOR CELL; EPIGENETICS; GLYCEMIC CONTROL; GLYCEMIC MEMORY; HUMAN; HYPERGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; REVIEW; STEM CELL MOBILIZATION; STEM CELL NICHE; ANIMAL; BIOLOGICAL MODEL; BLOOD; DIABETIC ANGIOPATHIES; GENETIC EPIGENESIS; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY;

ANIMALS; CELL DIFFERENTIATION; DIABETIC ANGIOPATHIES; DNA METHYLATION; ENDOTHELIAL PROGENITOR CELLS; EPIGENESIS, GENETIC; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; HYPERGLYCEMIA; MICRORNAS; MODELS, BIOLOGICAL; OXIDATIVE STRESS; STEM CELL NICHE;

EID: 84935874558     PISSN: 23146745     EISSN: 23146753     Source Type: Journal    
DOI: 10.1155/2015/436879     Document Type: Review

References (141)

1. R. L. Engerman and T. S. Kern, "Progression of incipient diabetic retinopathy during good glycemic control, " Diabetes, vol. 36, no. 7, pp. 808-812, 1987.
2. E. Vanballegooie, J. M. M. Hooymans, Z. Timmerman, et al., "Rapid deterioration of diabetic retinopathy during treatment with continuous subcutaneous insulin infusion, " Diabetes Care, vol. 7, no. 3, pp. 236-242, 1984.
3. K. Dahl-Jorgensen, O. Brinchmann-Hansen, and K. F. Hanssen, "Rapid tightening of blood glucose control leads to transient deterioration of retinopathy in insulin dependent diabetes mellitus: the Oslo study, " British Medical Journal, vol. 290, no. 6471, pp. 811-815, 1985.
4. H. Shamoon, H. Duffy, N. Fleischer, et al., "The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus, " The New England Journal of Medicine, vol. 329, no. 14, pp. 977-986, 1993.
5. M. W. Steffes, B. M. Chavers, M. E. Molitch, et al., "Sustained effect of intensive treatment of type 1 diabetes mellitus on development and progression of diabetic nephropathy-the Epidemiology of Diabetes Interventions and Complications (EDIC) study, " The Journal of the AmericanMedical Association, vol. 290, no. 16, pp. 2159-2167, 2003.
6. D. M. Nathan, "The diabetes control and complications trial/epidemiology of diabetes interventions and complications study at 30 years: overview, " Diabetes Care, vol. 37, no. 1, pp. 9-16, 2014.
7. M. A. Reddy, E. Zhang, and R. Natarajan, "Epigenetic mechanisms in diabetic complications and metabolic memory, " Diabetologia, vol. 58, no. 3, pp. 443-455, 2015.
8. M. A. Ihnat, J. E. Thorpe, and A. Ceriello, "Hypothesis: the metabolic memory, the new challenge of diabetes, " Diabetic Medicine, vol. 24, no. 6, pp. 582-586, 2007.
9. A. El-Osta, "Glycemic memory, " Current Opinion in Lipidology, vol. 23, no. 1, pp. 24-29, 2012.
10. T. A. Hillier, K. L. Pedula, M. M. Schmidt, J. A. Mullen, M.-A. Charles, and D. J. Pettitt, "Childhood obesity and metabolic imprinting: the ongoing effects of maternal hyperglycemia, " Diabetes Care, vol. 30, no. 9, pp. 2287-2292, 2007.
11. J. S. Teodoro, A. P. Gomes, A. T. Varela, F. V. Duarte, A. P. Rolo, and C. M. Palmeira, "Uncovering the beginning of diabetes: the cellular redox status and oxidative stress as starting players in hyperglycemic damage, " Molecular and Cellular Biochemistry, vol. 376, no. 1-2, pp. 103-110, 2013.
12. J. Chalmers and M. E. Cooper, "UKPDS and the legacy effect, " The New England Journal of Medicine, vol. 359, no. 15, pp. 1618-1620, 2008.
13. A. Ceriello, "Hypothesis: the metabolic memory, the new challenge of diabetes, " Diabetes Research and Clinical Practice, vol. 86, no. 1, pp. S2-S6, 2009.
14. International Diabetes Federation, IDF Diabetes Atlas, International Diabetes Federation, Brussels, Belgium, 6th edition, 2013-2014.
15. L. Guariguata, D. Whiting, I. Hambleton, J. Beagley, U. Linnenkamp, and J. Shaw, "Global estimates of diabetes prevalence for 2013 and projections for 2035, " Diabetes Research and Clinical Practice, vol. 103, no. 2, pp. 137-149, 2014.
16. C. Rask-Madsen and G. King, "Vascular complications of diabetes: mechanisms of injury and protective factors, " Cell Metabolism, vol. 17, no. 1, pp. 20-33, 2013.
17. J. R. Gavin, K. Alberti, M. B. Davidson, et al., "Report of the expert committee on the diagnosis and classification of diabetes mellitus, " Diabetes Care, vol. 20, no. 7, pp. 1183-1197, 1997.
18. M. J. Fowler, "Microvascular and macrovascular complications of diabetes, " Clinical Diabetes, vol. 26, no. 2, pp. 77-82, 2008.
19. G. L. Booth and B. Zinman, "Diabetes: progress in reducing vascular complications of diabetes, " Nature Reviews Endocrinology, vol. 10, no. 8, pp. 451-453, 2014.
20. C. S. Fox, S. Coady, P. D. Sorlie, et al., "Trends in cardiovascular complications of diabetes, " Journal of the American Medical Association, vol. 292, no. 20, pp. 2495-2499, 2004.
21. S. Roy, R. Sala, E. Cagliero, and M. Lorenzi, "Overexpression of fibronectin induced by diabetes or high glucose: phenomenon with amemory, " Proceedings of theNational Academy of Sciences of the United States of America, vol. 87, no. 1, pp. 404-408, 1990.
22. A. El-Osta, D. Brasacchio, D. C. Yao, et al., "Transient high glucose causes persistent epigenetic changes and altered gene expression during subsequent normoglycemia, " The Journal of Experimental Medicine, vol. 205, no. 10, pp. 2409-2417, 2008.
23. F. Paneni, P. Mocharla, A. Akhmedov, et al., "Gene silencing of the mitochondrial adaptor p66 suppresses vascular hyperglycemic memory in diabetes, " Circulation Research, vol. 111, no. 3, pp. 278-289, 2012.
24. M. Corgnali, L. Piconi, M. Ihnat, and A. Ceriello, "Evaluation of gliclazide ability to attenuate the hyperglycaemic memory induced by high glucose in isolated human endothelial cells, " Diabetes/Metabolism Research and Reviews, vol. 24, no. 4, pp. 301-309, 2008.
25. Z. Zheng, H. B. Chen, J. Li, et al., "Sirtuin 1-mediated cellular metabolic memory of high glucose via the LKB1/AMPK/ROS pathway and therapeutic effects ofmetformin, " Diabetes, vol. 61, no. 1, pp. 217-228, 2012.
26. H.-P. Hammes, I. Klinzing, S. Wiegand, R. G. Bretzel, A. M. Cohen, and K. Federlin, "Islet transplantation inhibits diabetic retinopathy in the sucrose-fed diabetic Cohen rat, " Investigative Ophthalmology & Visual Science, vol. 34, no. 6, pp. 2092-2096, 1993.
27. R. A. Kowluru, M. Kanwar, and A. Kennedy, "Metabolic memory phenomenon and accumulation of peroxynitrite in retinal capillaries, " Experimental Diabetes Research, vol. 2007, Article ID 21976, 7 pages, 2007.
28. R. A. Kowluru and P.-S. Chan, "Metabolic memory in diabetes-from in vitro oddity to in vivo problem: role of Apoptosis, " Brain Research Bulletin, vol. 81, no. 2-3, pp. 297-302, 2010.
29. R. A. Kowluru, "Effect of reinstitution of good glycemic control on retinal oxidative stress and nitrative stress in diabetic rats, " Diabetes, vol. 52, no. 3, pp. 818-823, 2003.
30. L. M. Villeneuve, M. A. Reddy, L. L. Lanting, M. Wang, L. Meng, and R. Natarajan, "Epigenetic histone H3 lysine 9 methylation in metabolic memory and inflammatory phenotype of vascular smooth muscle cells in diabetes, " Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 26, pp. 9047-9052, 2008.
31. P. Reichard, B. Berglund, A. Britz, I. Cars, B. Y. Nilsson, and U. Rosenqvist, "Intensified conventional insulin treatment retards the microvascular complications of insulin-dependent diabetes mellitus (IDDM): the Stockholm Diabetes Intervention Study (SDIS) after 5 years, " Journal of Internal Medicine, vol. 230, no. 2, pp. 101-108, 1991.
32. J. M. Lachin and D. E. R. Grp, "Effect of intensive diabetes therapy on the progression of diabetic retinopathy in patients with type 1 diabetes: 18 years of follow-up in the DCCT/EDIC, " Diabetes, vol. 64, no. 2, pp. 631-642, 2015.
33. B. Fullerton, K. Jeitler, M. Seitz, K. Horvath, A. Berghold, and A. Siebenhofer, "Intensive glucose control versus conventional glucose control for type 1 diabetes mellitus, " Cochrane Database of Systematic Reviews, vol. 2, 2014.
34. Y. Ohkubo, H. Kishikawa, E. Araki, et al., "Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a rand omized prospective 6-year study, " Diabetes Research and Clinical Practice, vol. 28, no. 2, pp. 103-117, 1995.
35. P. Gaede, P. Vedel, N. Larsen, G. V. H. Jensen, H.-H. Parving, and O. Pedersen, "Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes, " The New England Journal of Medicine, vol. 348, no. 5, pp. 383-393, 2003.
36. R. Turner, "Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33), " The Lancet, vol. 352, no. 9131, pp. 837-853, 1998.
37. R. R. Holman, S. K. Paul, M. A. Bethel, D. R. Matthews, and H. A. W. Neil, "10-year follow-up of intensive glucose control in type 2 diabetes, "The New England Journal of Medicine, vol. 359, no. 15, pp. 1577-1589, 2008.
38. W. Duckworth, C. Abraira, T. Moritz, et al., "Glucose control and vascular complications in veterans with type 2 diabetes, " The New England Journal of Medicine, vol. 360, no. 2, pp. 129-139, 2009.
39. N. Azad, L. Agrawal, N. V. Emanuele, R. Klein, G. D. Bahn, and P. Reaven, "Association of blood glucose control and pancreatic reserve with diabetic retinopathy in the Veterans Affairs Diabetes Trial (VADT), " Diabetologia, vol. 57, no. 6, pp. 1124-1131, 2014.
40. A. Patel, S. MacMahon, J. Chalmers, et al., "Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes, "The New England Journal ofMedicine, vol. 358, no. 24, pp. 2560-2572, 2008.
41. H. C. Gerstein, M. E. Miller, R. P. Byington, D. C. Goff, J. T. Bigger, and J. B. Buse, "Effects of intensive glucose lowering in type 2 diabetes, "The New England Journal of Medicine, vol. 358, no. 24, pp. 2545-2559, 2008.
42. A. Brown, L. R. Reynolds, and D. Bruemmer, "Intensive glycemic control and cardiovascular disease: an update, " Nature Reviews Cardiology, vol. 7, no. 7, pp. 369-375, 2010.
43. A. Saremi, D. C. Schwenke, G. Bahn, L. Ge, N. Emanuele, and P. D. Reaven, "The effect of intensive glucose lowering therapy among major racial/ethnic groups in the veterans affairs diabetes trial, " Metabolism, vol. 64, no. 2, pp. 218-225, 2015.
44. S. Akalin, K. Berntorp, A. Ceriello, et al., "Intensive glucose therapy and clinical implications of recent data: a consensus statement from the Global Task Force on Glycaemic Control, " International Journal of Clinical Practice, vol. 63, no. 10, pp. 1421-1425, 2009.
45. S. Del Prato, "Megatrials in type 2 diabetes. From excitement to frustration?" Diabetologia, vol. 52, no. 7, pp. 1219-1226, 2009.
46. M. Brownlee, "The pathobiology of diabetic complications-a unifying mechanism, " Diabetes, vol. 54, no. 6, pp. 1615-1625, 2005.
47. T. Nishikawa, D. Edelstein, and M. Brownlee, "The missing link: a single unifying mechanism for diabetic complications, " Kidney International, Supplement, vol. 58, no. 77, pp. S26-S30, 2000.
48. M. A. Ihnat, J. E. Thorpe, C. D. Kamat, et al., "Reactive oxygen species mediate a cellular memory of high glucose stress signalling, " Diabetologia, vol. 50, no. 7, pp. 1523-1531, 2007.
49. J. Drzewoski, J. Kasznicki, and Z. Trojanowski, "The role of metabolic memory in the natural history of diabetes mellitus, " Polskie Archiwum Medycyny Wewnetrznej, vol. 119, no. 7-8, pp. 493-500, 2009.
50. A. W. Stitt, "The role of advanced glycation in the pathogenesis of diabetic retinopathy, " Experimental and Molecular Pathology, vol. 75, no. 1, pp. 95-108, 2003.
51. A. Boveris, L. B. Valdez, T. Zaobornyj, and J. Bustamante, "Mitochondrial metabolic states regulate nitric oxide and hydrogen peroxide diffusion to the cytosol, " Biochimicaet Biophysica Acta-Bioenergetics, vol. 1757, no. 5-6, pp. 535-542, 2006.
52. S. A. Madsen-Bouterse, Q. Zhong, G. Mohammad, Y.-S. Ho, and R. A. Kowluru, "Oxidative damage of mitochondrial DNA in diabetes and its protection by manganese superoxide dismutase, " Free Radical Research, vol. 44, no. 3, pp. 313-321, 2010.
53. Y. Rikitake and J. K. Liao, "Rho-kinasemediates hyperglycemiainduced plasminogen activator inhibitor-1 expression in vascular endothelial cells, " Circulation, vol. 111, no. 24, pp. 3261-3268, 2005.
54. F. Umeda, Y. Ono, M. Masakado, et al., "Prostacyclin-stimulating factor, novel protein, and diabetic angiopathy, " Diabetes, vol. 45, no. 7, pp. S111-S113, 1996.
55. C. Grutzmacher, S. Park, Y. Zhao, M. E. Morrison, N. Sheibani, and C. M. Sorenson, "Aberrant production of extracellular matrix proteins and dysfunction in kidney endothelial cells with a short duration of diabetes, " The American Journal of Physiology-Renal Physiology, vol. 304, no. 1, pp. F19-F30, 2013.
56. P. J. Thornalley, "Protein and nucleotide damage by glyoxal and methylglyoxal in physiological systems-role in ageing and disease, " DrugMetabolismand Drug Interactions, vol. 23, no. 1-2, pp. 125-150, 2008.
57. M. G. Rosca, V. M. Monnier, L. I. Szweda, and M. F. Weiss, "Alterations in renal mitochondrial respiration in response to the reactive oxoaldehyde methylglyoxal, " American Journal of Physiology-Renal Physiology, vol. 283, no. 1, pp. F52-F59, 2002.
58. M. G. Rosca, T. G. Mustata, M. T. Kinter, et al., "Glycation of mitochondrial proteins from diabetic rat kidney is associated with excess superoxide formation, " American Journal of Physiology: Renal Physiology, vol. 289, no. 2, pp. F420-F430, 2005.
59. M.-P. Wautier, O. Chappey, S. Corda, D. M. Stern, A. M. Schmidt, and J.-L. Wautier, "Activation of NADPH oxidase by AGE links oxidant stress to altered gene expression via RAGE, " The American Journal of Physiology-Endocrinology and Metabolism, vol. 280, no. 5, pp. E685-E694, 2001.
60. S. Genuth, W. J. Sun, P. Cleary, et al., "Glycation and carboxymethyllysine levels in skin collagen predict the risk of future 10-year progression of diabetic retinopathy and nephropathy in the diabetes control and complications trial and epidemiology of diabetes interventions and complications participants with type 1 diabetes, " Diabetes, vol. 54, no. 11, pp. 3103-3111, 2005.
61. A. Prasad, P. Bekker, and S. Tsimikas, "Advanced glycation end products and diabetic cardiovascular disease, " Cardiology in Review, vol. 20, no. 4, pp. 177-183, 2012.
62. R. Meerwaldt, T. Links, C. Zeebregts, R. Tio, J.-L. Hillebrand s, and A. Smit, "The clinical relevance of assessing advanced glycation endproducts accumulation in diabetes, " Cardiovascular Diabetology, vol. 7, article 29, 2008.
63. R. Holliday, "Theinheritance of epigenetic defects, " Science, vol. 238, no. 4824, pp. 163-170, 1987.
64. L.-S. Fetita, E. Sobngwi, P. Serradas, F. Calvo, and J.-F. Gautier, "Review: consequences of fetal exposure tomaternal diabetes in offspring, " The Journal of Clinical Endocrinology & Metabolism, vol. 91, no. 10, pp. 3718-3724, 2006.
65. E. Ho, J. D. Clarke, and R. H. Dashwood, "Dietary sulforaphane, a histone deacetylase inhibitor for cancer prevention, " Journal of Nutrition, vol. 139, no. 12, pp. 2393-2396, 2009.
66. A. Barski, S. Cuddapah, K. Cui, et al., "High-resolution profiling of histone methylations in the human genome, " Cell, vol. 129, no. 4, pp. 823-837, 2007.
67. S. B. Rothbart and B. D. Strahl, "Interpreting the language of histone and DNA modifications, " Biochimicaet Biophysica Acta-Gene Regulatory Mechanisms, vol. 1839, no. 8, pp. 627-643, 2014.
68. D. E. Hand y, R. Castro, and J. Loscalzo, "Epigenetic modifications: basic mechanisms and role in cardiovascular disease, " Circulation, vol. 123, no. 19, pp. 2145-2156, 2011.
69. C. Martin and Y. Zhang, "Thediverse functions of histone lysine methylation, " Nature Reviews Molecular Cell Biology, vol. 6, no. 11, pp. 838-849, 2005.
70. D. Schubeler, "Function and information content of DNA methylation, " Nature, vol. 517, no. 7534, pp. 321-326, 2015.
71. M. Okano, D. W. Bell, D. A. Haber, and E. Li, "DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development, " Cell, vol. 99, no. 3, pp. 247-257, 1999.
72. A. P. Wolffe, P. L. Jones, and P. A. Wade, "DNA demethylation, " Proceedings of the National Academy of Sciences of the United States of America, vol. 96, no. 11, pp. 5894-5896, 1999.
73. H. Cedar and Y. Bergman, "Linking DNA methylation and histone modification: patterns and paradigms, " Nature Reviews Genetics, vol. 10, no. 5, pp. 295-304, 2009.
74. T. Hashimshony, J. M. Zhang, I. Keshet, M. Bustin, and H. Cedar, "The role of DNA methylation in setting up chromatin structure during development, " Nature Genetics, vol. 34, no. 2, pp. 187-192, 2003.
75. L. He and G. J. Hannon, "MicroRNAs: small RNAs with a big role in gene regulation, " Nature Reviews Genetics, vol. 5, no. 7, pp. 522-531, 2004.
76. F. Miao, Z. Chen, S. Genuth, et al., "Evaluating the role of epigenetic histone modifications in the metabolic memory of type 1 diabetes, " Diabetes, vol. 63, no. 5, pp. 1748-1762, 2014.
77. Q. Zhong and R. A. Kowluru, "Epigenetic modification of Sod2 in the development of diabetic retinopathy and in the metabolic memory: role of histone methylation, " Investigative Ophthalmology & Visual Science, vol. 54, no. 1, pp. 244-250, 2013.
78. Q. Zhong and R. A. Kowluru, "Epigenetic changes in mitochondrial superoxide dismutase in the retina and the development of diabetic retinopathy, " Diabetes, vol. 60, no. 4, pp. 1304-1313, 2011.
79. Q. Zhong and R. A. Kowluru, "Role of histone acetylation in the development of diabetic retinopathy and the metabolicmemory phenomenon, " Journal of Cellular Biochemistry, vol. 110, no. 6, pp. 1306-1313, 2010.
80. D. Brasacchio, J. Okabe, C. Tikellis, et al., "Hyperglycemia induces a dynamic cooperativity of histone methylase and demethylase enzymes associated with gene-activating epigenetic marks that coexist on the lysine tail, " Diabetes, vol. 58, no. 5, pp. 1229-1236, 2009.
81. J. Okabe, C. Orlowski, A. Balcerczyk, et al., "Distinguishing hyperglycemic changes by set7 in vascular endothelial cells, " Circulation Research, vol. 110, no. 8, pp. 1067-1076, 2012.
82. Y. Li, M. A. Reddy, F. Miao, et al., "Role of the histone H3 lysine 4 methyltransferase, SET7/9, in the regulation of NFkappaB-dependent inflammatory genes: relevance to diabetes and inflammation, "The Journal of Biological Chemistry, vol. 283, no. 39, pp. 26771-26781, 2008.
83. S. L. Chen, B. Feng, B. George, R. Chakrabarti, M. Chen, and S. Chakrabarti, "Transcriptional coactivator p300 regulates glucose-induced gene expression in endothelial cells, " The American Journal of Physiology-Endocrinology and Metabolism, vol. 298, no. 1, pp. E127-E137, 2010.
84. M. D. Shahbazian and M. Grunstein, "Functions of sitespecific histone acerylation and deacetylation, " Annual Review of Biochemistry, vol. 76, no. 1, pp. 75-100, 2007.
85. H. Hess-Stumpp, "Histone deacetylase inhibitors and cancer: fromcell biology to the clinic, " European Journal of Cell Biology, vol. 84, no. 2-3, pp. 109-121, 2005.
86. M. Potente, L. Ghaeni, D. Baldessari, et al., "SIRT1 controls endothelial angiogenic functions during vascular growth, " Genes & Development, vol. 21, no. 20, pp. 2644-2658, 2007.
87. G. Arunachalam, S. M. Samuel, I. Marei, H. Ding, and C. R. Triggle, "Metformin modulates hyperglycaemia-induced endothelial senescence and apoptosis through SIRT1, " British Journal of Pharmacology, vol. 171, no. 2, pp. 523-535, 2014.
88. K. E. Paschalaki, R. D. Starke, Y. Hu, et al., "Dysfunction of endothelial progenitor cells from smokers and chronic obstructive pulmonary disease patients due to increased dna damage and senescence, " Stem Cells, vol. 31, no. 12, pp. 2813-2826, 2013.
89. J. E. Fish, C. C. Matouk, A. Rachlis, et al., "The expression of endothelial nitric-oxide synthase is controlled by a cell-specific histone code, " The Journal of Biological Chemistry, vol. 280, no. 26, pp. 24824-24838, 2005.
90. K. Ohtani, G. J. Vlachojannis, M. Koyanagi, et al., "Epigenetic regulation of endothelial lineage committed genes in proangiogenic hematopoietic and endothelial progenitor cells, " Circulation Research, vol. 109, no. 11, pp. 1219-1229, 2011.
91. D.-A. Tregouet, P.-H. Groop, S. McGinn, et al., "G/T Substitution in Intron 1 of the UNC13B gene is associated with increased risk of nephropathy in patients with type 1 diabetes, " Diabetes, vol. 57, no. 10, pp. 2843-2850, 2008.
92. L. K. Park, A. G. Maione, A. Smith, et al., "Genome-wide DNA methylation analysis identifies a metabolic memory profile in patient-derived diabetic foot ulcer fibroblasts, " Epigenetics, vol. 9, no. 10, pp. 1339-1349, 2014.
93. S. Tewari, Q. Zhong, J. M. Santos, and R. A. Kowluru, "Mitochondria DNA replication and DNA methylation in the metabolic memory associated with continued progression of diabetic retinopathy, " Investigative Ophthalmology & Visual Science, vol. 53, no. 8, pp. 4881-4888, 2012.
94. J. Dunn, H. W. Qiu, S. Kim, et al., "Flow-dependent epigenetic DNA methylation regulates endothelial gene expression and atherosclerosis, " Journal of Clinical Investigation, vol. 124, no. 7, pp. 3187-3199, 2014.
95. A. Zampetaki, S. Kiechl, I. Drozdov, et al., "Plasma MicroRNA profiling reveals loss of endothelial MiR-126 and otherMicroRNAs in type 2 diabetes, " Circulation Research, vol. 107, no. 6, pp. 810-817, 2010.
96. A. D. McClelland and P. Kantharidis, "microRNA in the development of diabetic complications, " Clinical Science, vol. 126, no. 2, pp. 95-110, 2014.
97. J. Krutzfeldt, S. Kuwajima, R. Braich, et al., "Specificity, duplex degradation and subcellular localization of antagomirs, " Nucleic Acids Research, vol. 35, no. 9, pp. 2885-2892, 2007.
98. J. Krutzfeldt, N. Rajewsky, R. Braich, et al., "Silencing of microRNAs in vivo with antagomirs, " Nature, vol. 438, no. 7068, pp. 685-689, 2005.
99. S. Rafii and D. Lyden, "Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration, " Nature Medicine, vol. 9, no. 6, pp. 702-712, 2003.
100. N. Werner, S. Kosiol, T. Schiegl, et al., "Circulating endothelial progenitor cells and cardiovascular outcomes, " The New England Journal of Medicine, vol. 353, no. 10, pp. 999-1007, 2005.
101. R. J. Medina, C. L. ONeill, T. M. ODoherty, S. E. J. Wilson, and A. W. Stitt, "Endothelial progenitors as tools to study vascular disease, " Stem Cells International, vol. 2012, Article ID346735, 5 pages, 2012.
102. T. Asahara, T. Murohara, A. Sullivan, et al., "Isolation of putative progenitor endothelial cells for angiogenesis, " Science, vol. 275, no. 5302, pp. 964-967, 1997.
103. M. C. Yoder, "Defining human endothelial progenitor cells, " Journal ofThrombosis and Haemostasis, vol. 7, pp. 49-52, 2009.
104. J. Hur, C. H. Yoon, H. S. Kim, et al., "Characterization of two types of endothelial progenitor cells and their different contributions to neovasculogenesis, " Arteriosclerosis Thrombosis and Vascular Biology, vol. 24, no. 2, pp. 288-293, 2004.
105. R. J. Medina, C. L. ONeill, M. Sweeney, et al., "Molecular analysis of endothelial progenitor cell (EPC) subtypes reveals two distinct cell populations with different identities, " BMC Medical Genomics, vol. 3, article 18, 2010.
106. R. J. Medina, C. L. ONeill, T. M. ODoherty, et al., "Myeloid angiogenic cells act as alternative M2 macrophages and modulate angiogenesis through interleukin-8., "MolecularMedicine, vol. 17, no. 9-10, pp. 1045-1055, 2011.
107. Y. Lin, D. J. Weisdorf, A. Solovey, and R. P. Hebbel, "Origins of circulating endothelial cells and endothelial outgrowth from blood, " The Journal of Clinical Investigation, vol. 105, no. 1, pp. 71-77, 2000.
108. M. C. Yoder, L. E. Mead, D. Prater, et al., "Redefining endothelial progenitor cells via clonal analysis and hematopoietic stem/progenitor cell principals, " Blood, vol. 109, no. 5, pp. 1801-1809, 2007.
109. R. J. Medina, C. L. ONeill, M. W. Humphreys, T. A. Gardiner, and A. W. Stitt, "Outgrowth endothelial cells: characterization and their potential for reversing ischemic retinopathy, " InvestigativeOphthalmology& Visual Science, vol. 51, no. 11, pp. 5906-5913, 2010.
110. A. Reinisch, N. A. Hofmann, A. C. Obenauf, et al., "Humanized large-scale expand ed endothelial colony-forming cells function in vitro and in vivo, " Blood, vol. 113, no. 26, pp. 6716-6725, 2009.
111. N. Prasain, M. R. Lee, S. Vemula, et al., "Differentiation of human pluripotent stem cells to cells similar to cord-blood endothelial colony-forming cells, " Nature Biotechnology, vol. 32, no. 11, pp. 1151-1157, 2014.
112. R. S. Alphonse, A. Vadivel, M. Fung, et al., "Existence, functional impairment, and lung repair potential of endothelial colonyforming cells in oxygen-induced arrested alveolar growth, " Circulation, vol. 129, no. 21, pp. 2144-2157, 2014.
113. R. Z. Lin, R. Moreno-Luna, R. Munoz-Hernand ez, et al., "Human white adipose tissue vasculature contains endothelial colony-forming cells with robust in vivo vasculogenic potential, " Angiogenesis, vol. 16, no. 4, pp. 735-744, 2013.
114. J. Patel, E. Seppanen, M. S. Chong, et al., "Prospective surface marker-based isolation and expansion of fetal endothelial colony-forming cells from human term placenta, " Stem Cells Translational Medicine, vol. 2, no. 11, pp. 839-847, 2013.
115. S. Rafii, S. Meeus, S. Dias, et al., "Contribution of marrowderived progenitors to vascular and cardiac regeneration, " Seminars in Cell & Developmental Biology, vol. 13, no. 1, pp. 61-67, 2002.
116. S. Francis, "Endothelial progenitor cells and coronary artery disease, " Heart, vol. 90, no. 6, pp. 591-592, 2004.
117. M. C. Yoder, "Is endothelium the origin of endothelial progenitor cells?" Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 30, no. 6, pp. 1094-1103, 2010.
118. E. Zengin, F. Chalajour, U. M. Gehling, et al., "Vascular wall resident progenitor cells: a source for postnatal vasculogenesis, " Development, vol. 133, no. 8, pp. 1543-1551, 2006.
119. C. L. ONeill, M. T. ODoherty, S. E. Wilson, et al., "Therapeutic revascularisation of ischaemic tissue: the opportunities and challenges for therapy using vascular stem/progenitor cells, " Stem Cell Research and Therapy, vol. 3, no. 4, article 31, 2012.
120. D. J. Ceradini, A. R. Kulkarni, M. J. Callaghan, et al., "Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1, " Nature Medicine, vol. 10, no. 8, pp. 858-864, 2004.
121. C. J. M. Loomans, E. J. P. de Koning, F. J. T. Staal, et al., "Endothelial progenitor cell dysfunction-a novel concept in the pathogenesis of vascular complications of type 1 diabetes, " Diabetes, vol. 53, no. 1, pp. 195-199, 2004.
122. C. G. Egan, R. Lavery, F. Caporali, et al., "Generalised reduction of putative endothelial progenitors and CXCR4-positive peripheral blood cells in type 2 diabetes, " Diabetologia, vol. 51, no. 7, pp. 1296-1305, 2008.
123. O. M. Tepper, R. D. Galiano, J. M. Capla, et al., "Human endothelial progenitor cells from type II diabetics exhibit impaired proliferation, adhesion, and incorporation into vascular structures, " Circulation, vol. 106, no. 22, pp. 2781-2786, 2002.
124. G. P. Fadini, S. Sartore, M. Schiavon, et al., "Diabetes impairs progenitor cell mobilisation after hindlimb ischaemiareperfusion injury in rats, " Diabetologia, vol. 49, no. 12, pp. 3075-3084, 2006.
125. D. A. Ingram, I. Z. Lien, L. E. Mead, et al., "In vitro hyperglycemia or a diabetic intrauterine environment reduces neonatal endothelial colony-forming cell numbers and function, " Diabetes, vol. 57, no. 3, pp. 724-731, 2008.
126. J. V. Busik, M. Tikhonenko, A. Bhatwadekar, et al., "Diabetic retinopathy is associated with bone marrow neuropathy and a depressed peripheral clock, " The Journal of Experimental Medicine, vol. 206, no. 13, pp. 2897-2906, 2009.
127. Y. Maeng, J. Y. Kwon, E. K. Kim, and Y. G. Kwon, "Heterochromatin protein 1 alpha (HP1β: CBX5) is a key regulator in differentiation of endothelial progenitor cells to endothelial cells, " Stem Cells, vol. 33, no. 5, pp. 1512-1522, 2015.
128. L. Rossig, C. Urbich, T. Bruhl, et al., "Histone deacetylase activity is essential for the expression of HoxA9 and for endothelial commitment of progenitor cells, " The Journal of Experimental Medicine, vol. 201, no. 11, pp. 1825-1835, 2005.
129. S. Fraineau, C. G. Palii, D. S. Allan, and M. Brand, "Epigenetic regulation of endothelial-cell-mediated vascular repair, " The FEBS Journal, vol. 282, no. 9, pp. 1605-1629, 2015.
130. C. G. Palii, B. Vulesevic, S. Fraineau, et al., "Trichostatin a enhances vascular repair by injected human endothelial progenitors through increasing the expression of TAL1-dependent genes, " Cell Stem Cell, vol. 14, no. 5, pp. 644-657, 2014.
131. T. He, T. E. Peterson, E. L. Holmuhamedov, et al., "Human endothelial progenitor cells tolerate oxidative stress due to intrinsically high expression of manganese superoxide dismutase, " Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 24, no. 11, pp. 2021-2027, 2004.
132. D. A. Ingram, T. R. Krier, L. E. Mead, et al., "Clonogenic endothelial progenitor cells are sensitive to oxidative stress, " Stem Cells, vol. 25, no. 2, pp. 297-304, 2007.
133. M. Ii, H. Takenaka, J. Asai, et al., "Endothelial progenitor thrombospondin-1 mediates diabetes-induced delay in reendothelialization following arterial injury, " Circulation Research, vol. 98, no. 5, pp. 697-704, 2006.
134. C. Urbich, E. Dernbach, L. Rossig, A. M. Zeiher, and S. Dimmeler, "High glucose reduces cathepsin L activity and impairs invasion of circulating progenitor cells, " Journal of Molecular and Cellular Cardiology, vol. 45, no. 3, pp. 429-436, 2008.
135. R. J. Medina, C. L. Oneill, T. M. Odoherty, et al., "Ex vivo expansion of human outgrowth endothelial cells leads to IL-8-mediated replicative senescence and impaired vasoreparative function, " Stem Cells, vol. 31, no. 8, pp. 1657-1668, 2013.
136. T. Yokoi, K. Fukuo, O. Yasuda, et al., "Apoptosis signal-regulating kinase 1mediates cellular senescence induced by high glucose in endothelial cells, " Diabetes, vol. 55, no. 6, pp. 1660-1665, 2006.
137. C. Liang, Y. Ren, H. Tan, et al., "Rosiglitazone via upregulation of Akt/eNOS pathways attenuates dysfunction of endothelial progenitor cells, induced by advanced glycation end products, " British Journal of Pharmacology, vol. 158, no. 8, pp. 1865-1873, 2009.
138. H. J. Cho, H. S. Kim, M. M. Lee, et al., "Mobilized endothelial progenitor cells by granulocyte-macrophage colonystimulating factor accelerate reendothelialization and reduce vascular inflammation after intravascular radiation, " Circulation, vol. 108, no. 23, pp. 2918-2925, 2003.
139. M. S. Segal, R. Shah, A. Afzal, et al., "Nitric oxide cytoskeletalinduced alterations reverse the endothelial progenitor cell migratory defect associated with diabetes, " Diabetes, vol. 55, no. 1, pp. 102-109, 2005.
140. O. Awad, C. Jiao, N. Ma, M. Dunnwald, and G. C. Schatteman, "Obese diabeticmouse environment differentially affects primitive and monocytic endothelial cell progenitors, " StemCells, vol. 23, no. 4, pp. 575-583, 2005.
141. A. D. Bhatwadekar, J. V. Glenn, G. Li, T. M. Curtis, T. A. Gardiner, and A. W. Stitt, "Advanced glycation of fibronectin impairs vascular repair by endothelial progenitor cells: implications for vasodegeneration in diabetic retinopathy, " Investigative Ophthalmology & Visual Science, vol. 49, no. 3, pp. 1232-1241, 2008.